These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Role of KCNJ5 in familial and sporadic primary aldosteronism. Mulatero P; Monticone S; Rainey WE; Veglio F; Williams TA Nat Rev Endocrinol; 2013 Feb; 9(2):104-12. PubMed ID: 23229280 [TBL] [Abstract][Full Text] [Related]
47. Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel. Velarde-Miranda C; Gomez-Sanchez EP; Gomez-Sanchez CE Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):895-901. PubMed ID: 23829355 [TBL] [Abstract][Full Text] [Related]
48. Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients. Wang B; Li X; Zhang X; Ma X; Chen L; Zhang Y; Lyu X; Tang Y; Huang Q; Gao Y; Fan Y; Ouyang J Medicine (Baltimore); 2015 Apr; 94(16):e708. PubMed ID: 25906099 [TBL] [Abstract][Full Text] [Related]
49. [Primary aldosteronism: new insights into familial forms]. van den Meiracker AH; van der Linde AA; Claahsen van der Grinten HL; Danser AH; Deinum J Ned Tijdschr Geneeskd; 2015; 159():A8932. PubMed ID: 26420144 [TBL] [Abstract][Full Text] [Related]
51. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5. Scholl UI; Lifton RP Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698 [TBL] [Abstract][Full Text] [Related]
52. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma. Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532 [TBL] [Abstract][Full Text] [Related]
53. A revised mechanism of action of hyperaldosteronism-linked mutations in cytosolic domains of GIRK4 (KCNJ5). Shalomov B; Handklo-Jamal R; Reddy HP; Theodor N; Bera AK; Dascal N J Physiol; 2022 Mar; 600(6):1419-1437. PubMed ID: 34957562 [TBL] [Abstract][Full Text] [Related]
54. Targeted disruption of the Hardege I; Long L; Al Maskari R; Figg N; O'Shaughnessy KM Clin Sci (Lond); 2018 Jan; 132(1):145-156. PubMed ID: 29222092 [TBL] [Abstract][Full Text] [Related]
55. Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism. Yamazaki Y; Nakamura Y; Omata K; Ise K; Tezuka Y; Ono Y; Morimoto R; Nozawa Y; Gomez-Sanchez CE; Tomlins SA; Rainey WE; Ito S; Satoh F; Sasano H J Clin Endocrinol Metab; 2017 Apr; 102(4):1182-1192. PubMed ID: 28388725 [TBL] [Abstract][Full Text] [Related]
56. KCNJ5 Mutation Contributes to Complete Clinical Success in Aldosterone-Producing Adenoma: A Study From a Single Center. Zhang C; Wu L; Jiang L; Su T; Zhou W; Zhong X; Xie J; Sun F; Zhu Y; Jiang Y; Wang W Endocr Pract; 2021 Jul; 27(7):736-742. PubMed ID: 33678553 [TBL] [Abstract][Full Text] [Related]
57. Cardiovascular and metabolic characters of Chang YY; Lee BC; Chen ZW; Tsai CH; Chang CC; Liao CW; Pan CT; Peng KY; Chou CH; Lu CC; Wu VC; Hung CS; Lin YH; Front Endocrinol (Lausanne); 2023; 14():1061704. PubMed ID: 36950676 [TBL] [Abstract][Full Text] [Related]
58. Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia. Kometani M; Yoneda T; Demura M; Aono D; Gondoh Y; Karashima S; Nishimoto K; Yasuda M; Horike SI; Takeda Y Steroids; 2019 Nov; 151():108470. PubMed ID: 31400391 [TBL] [Abstract][Full Text] [Related]
59. GSTA1 Expression Is Correlated With Aldosterone Level in KCNJ5-Mutated Adrenal Aldosterone-Producing Adenoma. Li X; Wang B; Tang L; Zhang Y; Chen L; Gu L; Zhang F; Ouyang J; Zhang X J Clin Endocrinol Metab; 2018 Mar; 103(3):813-823. PubMed ID: 29165597 [TBL] [Abstract][Full Text] [Related]